Edge Therapeutics IPO Research Information

Edge Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Edge Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Edge Therapeutics	EDGE - NASDAQ	$14.00-$16.00	$11.00	$11.60	7.3 million	10/1/2015
Underwriter(s): Leerink Partners, Credit Suisse
Co-Manager(s): Guggenheim Securities, JMP Securities
Industry: Health Care
Filing(s): Filed 2015-08-14 Terms Added 2015-09-21

Edge Therapeutics Quote & Chart - Click for current quote - EDGE

About Edge Therapeutics (adapted from Edge Therapeutics prospectus):
They are a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening conditions.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "EDGE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.